Derrick S - Search Results

1

Nonclinical Development of BCG Replacement Vaccine Candidates.

Velmurugan K, Grode L, Chang R, Fitzpatrick M, Laddy D, Hokey D, Derrick S, Morris S, McCown D, Kidd R, Gengenbacher M, Eisele B, Kaufmann SH, Fulkerson J, Brennan MJ. Velmurugan K, et al. Among authors: derrick s. Vaccines (Basel). 2013 Apr 16;1(2):120-38. doi: 10.3390/vaccines1020120. Vaccines (Basel). 2013. PMID: 26343962 Free PMC article.

2

A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity.

Derrick SC, Yang AL, Morris SL. Derrick SC, et al. Vaccine. 2004 Dec 21;23(6):780-8. doi: 10.1016/j.vaccine.2004.07.036. Vaccine. 2004. PMID: 15542202

3

The ESAT6 protein of Mycobacterium tuberculosis induces apoptosis of macrophages by activating caspase expression.

Derrick SC, Morris SL. Derrick SC, et al. Cell Microbiol. 2007 Jun;9(6):1547-55. doi: 10.1111/j.1462-5822.2007.00892.x. Epub 2007 Feb 9. Cell Microbiol. 2007. PMID: 17298391

4

Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.

Sun R, Skeiky YA, Izzo A, Dheenadhayalan V, Imam Z, Penn E, Stagliano K, Haddock S, Mueller S, Fulkerson J, Scanga C, Grover A, Derrick SC, Morris S, Hone DM, Horwitz MA, Kaufmann SH, Sadoff JC. Sun R, et al. Among authors: derrick sc. Vaccine. 2009 Jul 16;27(33):4412-23. doi: 10.1016/j.vaccine.2009.05.048. Epub 2009 Jun 2. Vaccine. 2009. PMID: 19500523

5

Characterization of an intracellular ATP assay for evaluating the viability of live attenuated mycobacterial vaccine preparations.

Kolibab K, Derrick SC, Jacobs WR, Morris SL. Kolibab K, et al. J Microbiol Methods. 2012 Sep;90(3):245-9. doi: 10.1016/j.mimet.2012.05.015. Epub 2012 May 28. J Microbiol Methods. 2012. PMID: 22652432

6

Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis.

Derrick SC, Repique C, Snoy P, Yang AL, Morris S. Derrick SC, et al. Infect Immun. 2004 Mar;72(3):1685-92. doi: 10.1128/IAI.72.3.1685-1692.2004. Infect Immun. 2004. PMID: 14977976 Free PMC article.

7

Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.

Goter-Robinson C, Derrick SC, Yang AL, Jeon BY, Morris SL. Goter-Robinson C, et al. Vaccine. 2006 Apr 24;24(17):3522-9. doi: 10.1016/j.vaccine.2006.02.005. Epub 2006 Feb 20. Vaccine. 2006. PMID: 16519971

8

Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.

Derrick SC, Yabe IM, Yang A, Morris SL. Derrick SC, et al. Vaccine. 2011 Apr 5;29(16):2902-9. doi: 10.1016/j.vaccine.2011.02.010. Epub 2011 Feb 21. Vaccine. 2011. PMID: 21338678

9

Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice.

Derrick SC, Kolibab K, Yang A, Morris SL. Derrick SC, et al. Clin Vaccine Immunol. 2014 Oct;21(10):1443-51. doi: 10.1128/CVI.00394-14. Epub 2014 Aug 20. Clin Vaccine Immunol. 2014. PMID: 25143340 Free PMC article.

10

Effect of cationic liposomes on BCG trafficking and vaccine-induced immune responses following a subcutaneous immunization in mice.

Derrick SC, Yang A, Parra M, Kolibab K, Morris SL. Derrick SC, et al. Vaccine. 2015 Jan 1;33(1):126-32. doi: 10.1016/j.vaccine.2014.11.004. Epub 2014 Nov 15. Vaccine. 2015. PMID: 25448108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page